Mar. 18, 2008 A team led by Dr. Chris Tselepis at the University of Birmingham has investigated for the first time the relationship between hepcidin; a known regulator of iron metabolism and colorectal cancer. Results of the study suggest that circulating hepcidin levels are indicative of stage of colorectal cancer and also that a subset of colorectal tumours express this protein. This adds weight to the growing body of evidence pointing to the importance of iron metabolism in cancer.
Historically anaemia, which is associated with colorectal cancer, has been attributed to blood loss. Previous studies have elegantly shown that the anti-microbial peptide hepcidin can also induce anaemia as a consequence of infection and or inflammation. This type of anaemia has been termed anaemia of chronic disease. Thus the primary aim of the recent article was to address whether a component of the anaemia observed in colorectal cancer patients is due to raised hepcidin expression.
Using the technique of mass spectrometry Ward et al* clearly demonstrate that whilst circulating hepcidin levels were not associated with anaemia it was positively associated with stage of colorectal disease. Furthermore they show that this peptide which was previously thought to be predominantly expressed by the liver is also expressed in a subset of colorectal cancer tissues.
Dr Chris Tselepis suggests that this study could have ramifications in the diagnosis and treatment of colorectal cancer patients. Furthermore he states that it adds weight to an emerging body of evidence that iron at the level of cancer tissue may amplify carcinogenesis and may explain why early clinical studies using iron chelators have shown great promise.
What this study ultimately suggests is that cancer cells sequester as much iron as is possible so as to feed their high metabolic activity as well as driving cancer pathways. What iron is circulating is likely to be captured by the cellular iron import proteins which are expressed in abundance on the cancer cell surface. In addition, hepcidin expression in cancer cells will inhibit cellular iron export inducing an accumulation of iron thus perpetuating the cancer phenotype.
*Journal reference: Ward DG, Roberts K, Brookes MJ, Joy H, Martin A, Ismail T, Spychal R, Iqbal T, Tselepis C. Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol 2008; 14(9): 1339-1345
Other social bookmarking and sharing tools:
Note: If no author is given, the source is cited instead.